U.S. tightens grip on development bank to counter China's regional influence

What it does

This bill directs the U.S. Treasury Secretary and State Department to instruct the U.S. Executive Director at the Inter-American Development Bank (IDB) to use U.S. voting power and influence to reduce Chinese government and Chinese entity involvement in IDB projects, financing, and governance. It requires detailed reporting on all Chinese-funded or Chinese-contracted IDB projects, their risks to U.S. security interests, and procurement practices, with public summaries posted within 90 days. It also encourages the IDB to prioritize procurement from U.S. and allied countries and to collaborate more with the U.S. International Development Finance Corporation.

Why we flagged it

The bill's core mechanism is to use U.S. voting power and reporting requirements to constrain Chinese participation in a multilateral development bank. It is not a tax measure, appropriation, or regulatory carve-out; it is a foreign policy and governance tool aimed at a specific geopolitical rival.

What the text implies

• Increased reporting and scrutiny may slow IDB project approval timelines, potentially delaying development financing to Latin American countries and affecting their economic growth.
• Prioritizing U.S. and allied procurement over lowest-cost options may increase project costs, which could be passed to borrowing countries as higher loan terms or reduced project scope.
• The bill does not restrict Chinese voting power at the IDB directly—it only instructs the U.S. Executive Director to oppose Chinese-backed initiatives, meaning outcomes depend on coalition-building with other IDB members.
• Detailed public reporting on Chinese projects and entities may expose sensitive information about IDB governance vulnerabilities, potentially inviting further geopolitical competition in the institution.
• The 15-day notification requirement for new Chinese-involved projects creates an ongoing compliance burden on Treasury and State Department staff with no explicit appropriation.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill advances U.S. geopolitical and security interests by increasing transparency and scrutiny of Chinese influence in multilateral development finance—a legitimate public concern. However, the bill does not directly benefit ordinary U.S. citizens materially; its primary effect is to shift IDB governance and procurement practices in ways that may increase costs for Latin American borrowers if U.S. and allied procurement is more expensive than Chinese alternatives, potentially reducing develo

Who stands to gain

• U.S. construction and engineering firms (if procurement shifts from Chinese to U.S. contractors)
• U.S. International Development Finance Corporation (encouraged to expand collaboration with IDB)
• U.S. and allied country exporters and service providers

Named in the bill

Inter-American Development Bank (IDB), IDB Invest, IDB Lab, People's Republic of China (PRC), U.S. Treasury Department, U.S. State Department, U.S. International Development Finance Corporation (DFC), Federal Communications Commission (FCC), Department of Commerce Bureau of Industry and Security, World Bank, Taiwan

Where it stands

1 cosponsor: 1 Democrats.

• Jul 31, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Jul 31, 2025 — Referred to Senate Committee on Foreign Relations · Congress.gov: “Read twice and referred to the Committee on Foreign Relations”
• Oct 22, 2025 — Reported out of committee · Congress.gov: “Committee on Foreign Relations. Ordered to be reported with an amendment in the nature of a substitute…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $290,000 in lobbying spend. A filing names 26 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Dave McCormick, the sponsor, reported $690,750 in PAC receipts in the 2026 cycle.

• National Association of Chain Drug Stores — $290,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.